Pulmonx CEO and leadership

Glendon French is a President/CEO at Pulmonx and Board Member at Pulmonx. He has worked as Board Member at Cardiac Pathways Corp, Board Member at Asthmatx Inc, and Chief Executive Officer/Director at ApniCure Inc. Glendon works or has worked as TRUSTEE at The Oliver Fund. He attended DARTMOUTH COLLEGE and The Wharton School.

Medical technology executive with over 20 years experience leading growth in MedTech and over a decade in pulmonary devices, with experience spanning commercial, clinical and R&D.

Derrick brings to Pulmonx over 20 years of finance, strategy, and commercial experience across multiple facets of the medical device industry. Prior to joining Pulmonx, Derrick was Executive Vice President, Strategy & Corporate Development at iRhythm Technologies, Inc. (NASDAQ: IRTC), where he set strategic and financial direction for the company and helped guide iRhythm through a successful IPO. Prior to iRhythm, Derrick spent seven years on Wall Street as the senior equity research analyst covering the medical device sector for Sanford C. Bernstein & Company. Previously, Derrick was Director of Marketing and Business Development in Boston Scientific Corp.’s Neuromodulation Division; a management consultant at the Boston Consulting Group; and he started his career as an R&D engineer designing heart catheters for Guidant Corporation, now a part of Abbott Vascular. Derrick received his Ph.D. in Bioengineering from the University of California, San Diego; his MBA from San Diego State University, and his B.S. in Mechanical Engineering from Stanford University.

Glendon French is a President/CEO at Pulmonx and Board Member at Pulmonx. He has worked as Board Member at Cardiac Pathways Corp, Board Member at Asthmatx Inc, and Chief Executive Officer/Director at ApniCure Inc. Glendon works or has worked as TRUSTEE at The Oliver Fund. He attended DARTMOUTH COLLEGE and The Wharton School.